
From drug discovery to
Strategic translational science –
building the bridge to humans
We create excellent solutions to translate pre-clinical trial results into successful early human clinical trials.
Our expertise includes:
- innovative models and biomarkers translatable from in-vitro studies to rodent animal models to man.
- novel biomarkers and pharmacodynamic models in healthy volunteers
- innovative pharmacology and proof of concept clinical trial design, including outcome measures

Solutions-focused clinical development
We design clinical programs to address patients’, KOLs’, regulators’ and payors’ demands from early on – irrespective of indication, patient population or therapeutic approach.
Solutions focus:
In brief
- We are developing new Patient-Reported Outcome (PRO) measures for specific diseases to meet the needs of payors. We are the only company bringing PRO measures to early development in pain.
- Through our tapentadol paediatric program, we are conducting pioneering research and designing special protocols to drive solutions for babies, children and adolescents. We are strongly committed to the unique needs of children and their parents.
- In Latin America, we focus on projects to meet the specific needs in that region (pain, women’s health and CNS).
Our expertise includes:
- holistic clinical trial strategy and planning
- full clinical trial operations
- experienced CRO management
- best-in-class data management, data analysis and modelling, and simulation
Clinical Operations (CO) –
delivering high quality clinical trials
We collaborate with internal and external commercial partners to ensure the delivery of clinical trials in line with timelines, budget, and adherence to the highest quality and ethical standards.
Our Clinical Operations model
Our expertise includes:
- clinical trial management
- clinical trial oversight
- clinical trial supply
- data and documents operations
- quality management services and compliance